Research Activities During the Fellowship
Panu Wetwittayakhlang (12/7 papers as 1st author)
Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras – Results from Western Hungarian Population-based Inception Cohort between 1977-2020.Wetwittayakhlang P, Gonczi L, Lakatos L, Kurti Z, Golovics P, Pandur T, David G, Erdelyi Z, Szita I, Lakatos PL.J Crohns Colitis. 2022 Dec 20:jjac188. doi: 10.1093/ecco-jcc/jjac188. Online ahead of print.PMID: 36539328
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.Wetwittayakhlang P, Golovics PA, Khoury AA, Ganni E, Hahn GD, Cohen A, Wyse J, Bradette M, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL.J Gastrointestin Liver Dis. 2022 Dec 16;31(4):403-410. doi: 10.15403/jgld-4375.PMID: 36535055 Free article.
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study.Hahn GD, LeBlanc JF, Golovics PA, Wetwittayakhlang P, Qatomah A, Wang A, Boodaghians L, Liu Chen Kiow J, Al Ali M, Wild G, Afif W, Bitton A, Lakatos PL, Bessissow T.World J Gastroenterol. 2022 Sep 7;28(33):4823-4833. doi: 10.3748/wjg.v28.i33.4823.PMID: 36156919 Free PMC article.
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Hahn GD, Golovics PA, Wetwittayakhlang P, Santa Maria DM, Britto U, Wild GE, Afif W, Bitton A, Bessissow T, Lakatos PL.J Clin Med. 2022 Jul 29;11(15):4422. doi: 10.3390/jcm11154422.PMID: 35956040 Free PMC article. Review.
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials.Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL.J Clin Med. 2022 May 28;11(11):3045. doi: 10.3390/jcm11113045.PMID: 35683433 Free PMC article. Review.
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?Hahn GD, Golovics PA, Wetwittayakhlang P, Al Khoury A, Bessissow T, Lakatos PL.Biomedicines. 2022 Mar 23;10(4):749. doi: 10.3390/biomedicines10040749.PMID: 35453498 Free PMC article. Review.
Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn’s Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance.Hahn GD, Wetwittayakhlang P, Afif W, Bessissow T, Lakatos PL.Case Rep Gastroenterol. 2022 Mar 17;16(1):116-121. doi: 10.1159/000521919. eCollection 2022 Jan-Apr.PMID: 35528765 Free PMC article.
Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996-2015.Golovics PA, Verdon C, Wetwittayakhlang P, Filliter C, Gonczi L, Hahn GD, Wild GE, Afif W, Bitton A, Bessissow T, Brassard P, Lakatos PL.J Clin Med. 2022 Jan 28;11(3):686. doi: 10.3390/jcm11030686.PMID: 35160136 Free PMC article.
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.Wetwittayakhlang P, Albader F, Golovics PA, Hahn GD, Bessissow T, Bitton A, Afif W, Wild G, Lakatos PL.Can J Gastroenterol Hepatol. 2021 Nov 30;2021:7591141. doi: 10.1155/2021/7591141. eCollection 2021.PMID: 34858891 Free PMC article.
Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?Wetwittayakhlang P, Lontai L, Gonczi L, Golovics PA, Hahn GD, Bessissow T, Lakatos PL.J Clin Med. 2021 Nov 26;10(23):5551. doi: 10.3390/jcm10235551.PMID: 34884252 Free PMC article. Review.
Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis.Wetwittayakhlang P, Golovics PA, Afif W, Bessissow T, Lakatos PL.ACG Case Rep J. 2021 Nov 23;8(11):e00678. doi: 10.14309/crj.0000000000000678. eCollection 2021 Nov.PMID: 34840995 Free PMC article.
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!Wetwittayakhlang P, Lakatos PL.J Crohns Colitis. 2021 Nov 8;15(11):1783-1784. doi: 10.1093/ecco-jcc/jjab084.PMID: 34096579
Gustavo Hahn ( 9/4 papers as 1st author)
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.Wetwittayakhlang P, Golovics PA, Khoury AA, Ganni E, Hahn GD, Cohen A, Wyse J, Bradette M, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL.J Gastrointestin Liver Dis. 2022 Dec 16;31(4):403-410. doi: 10.15403/jgld-4375.PMID: 36535055 Free article.
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study.Hahn GD, LeBlanc JF, Golovics PA, Wetwittayakhlang P, Qatomah A, Wang A, Boodaghians L, Liu Chen Kiow J, Al Ali M, Wild G, Afif W, Bitton A, Lakatos PL, Bessissow T.World J Gastroenterol. 2022 Sep 7;28(33):4823-4833. doi: 10.3748/wjg.v28.i33.4823.PMID: 36156919 Free PMC article.
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.Hahn GD, Golovics PA, Wetwittayakhlang P, Santa Maria DM, Britto U, Wild GE, Afif W, Bitton A, Bessissow T, Lakatos PL.J Clin Med. 2022 Jul 29;11(15):4422. doi: 10.3390/jcm11154422.PMID: 35956040 Free PMC article. Review.
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials.Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL.J Clin Med. 2022 May 28;11(11):3045. doi: 10.3390/jcm11113045.PMID: 35683433 Free PMC article. Review.
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?Hahn GD, Golovics PA, Wetwittayakhlang P, Al Khoury A, Bessissow T, Lakatos PL.Biomedicines. 2022 Mar 23;10(4):749. doi: 10.3390/biomedicines10040749.PMID: 35453498 Free PMC article. Review.
Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn’s Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance. Hahn GD, Wetwittayakhlang P, Afif W, Bessissow T, Lakatos PL.Case Rep Gastroenterol. 2022 Mar 17;16(1):116-121. doi: 10.1159/000521919. eCollection 2022 Jan-Apr.PMID: 35528765 Free PMC article.
Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996-2015. Golovics PA, Verdon C, Wetwittayakhlang P, Filliter C, Gonczi L, Hahn GD, Wild GE, Afif W, Bitton A, Bessissow T, Brassard P, Lakatos PL.J Clin Med. 2022 Jan 28;11(3):686. doi: 10.3390/jcm11030686.PMID: 35160136 Free PMC article.
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Wetwittayakhlang P, Albader F, Golovics PA, Hahn GD, Bessissow T, Bitton A, Afif W, Wild G, Lakatos PL.Can J Gastroenterol Hepatol. 2021 Nov 30;2021:7591141. doi: 10.1155/2021/7591141. eCollection 2021.PMID: 34858891 Free PMC article.
Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?Wetwittayakhlang P, Lontai L, Gonczi L, Golovics PA, Hahn GD, Bessissow T, Lakatos PL.J Clin Med. 2021 Nov 26;10(23):5551. doi: 10.3390/jcm10235551.